EFFECT OF 5-LIPOXYGENASE INHIBITOR, VIA-2291, ON EPICARDIAL FAT VOLUME IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME

被引：0
|
作者：
Almeida, Shone [1 ]
Budhoff, Matthew [1 ]
机构：
[1] Los Angeles Biomed Res Inst, Torrance, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32134-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1593
引用
收藏
页码：1593 / 1593
页数：1
相关论文
共 50 条
  • [21] EFFECT OF A NEW SELECTIVE 5-LIPOXYGENASE INHIBITOR IN BIOCHEMICAL AND PHARMACOLOGICAL MODELS FOR THE INHIBITION OF ACUTE HYPERSENSITIVITY REACTIONS
    HAMMERBECK, DM
    BELL, RL
    STELZER, VL
    HEGHINIAN, K
    REITER, MJ
    SCHERRER, RA
    RUSTAD, MA
    HUPPERTS, AM
    SWINGLE, KF
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 524 : 398 - 401
  • [22] The Relationship between GRACE Risk Score and Epicardial Fat Thickness in Patients with Acute Coronary Syndrome
    Gul, Ilker
    Aykan, Ahmet Cagri
    Gokdeniz, Tayyar
    Boyaci, Faruk
    Kalaycioglu, Ezgi
    Bilgin, Murat
    Yildiz, Bekir Serhat
    Zungur, Mustafa
    Tastan, Ahmet
    Tamci, Necdet Batuhan
    Tavli, Talat
    Celik, Sukru
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C198 - C200
  • [23] EFFECT OF PIRIPROST, A 5-LIPOXYGENASE INHIBITOR, ON LEUKOCYTE ACCUMULATION DURING THIOGLYCOLLATE-INDUCED ACUTE-INFLAMMATION
    LAWSON, CF
    SMITH, HW
    FITZPATRICK, FA
    WIENER KLINISCHE WOCHENSCHRIFT, 1986, 98 (04) : 110 - 113
  • [24] Impact of Increased Epicardial Adipose Tissue Volume on Future Acute Coronary Syndrome in Patients with Coronary Artery Disease
    Nakanishi, Koki
    Fukuda, Shota
    Tanaka, Atsushi
    Otsuka, Kenichiro
    Sakamoto, Makoto
    Taguchi, Haruyuki
    Yoshikawa, Junichi
    Shimada, Kenei
    Yoshiyama, Minoru
    CIRCULATION, 2012, 126 (21)
  • [25] Cardiac 64-Multislice Computed Tomography Reveals an Association Between Epicardial Fat Volume and Acute Coronary Syndrome
    Harada, Ken
    Amano, Tetsuya
    Shimbo, Yusaku
    Kunimura, Ayako
    Kumagai, Soichiro
    Yokoi, Kiminobu
    Yoshida, Tomohiro
    Kato, Bunichi
    Uetani, Tadayuki
    Kato, Masataka
    Marui, Nobuyuki
    Nanki, Michio
    Matsubara, Tatsuaki
    Ishii, Hideki
    Murohara, Toyoaki
    CIRCULATION, 2009, 120 (18) : S346 - S346
  • [26] EFFECT OF A 5-LIPOXYGENASE INHIBITOR ON LEUKOTRIENE GENERATION AND AIRWAY RESPONSES AFTER ALLERGEN CHALLENGE IN ASTHMATIC-PATIENTS
    HUI, KP
    TAYLOR, IK
    TAYLOR, GW
    RUBIN, P
    KESTERSON, J
    BARNES, NC
    BARNES, PJ
    THORAX, 1991, 46 (03) : 184 - 189
  • [27] Zileuton, a 5-Lipoxygenase Inhibitor, Exerts Anti-Angiogenic Effect by Inducing Apoptosis of HUVEC via BK Channel Activation
    Lim, Hyun-Joung
    Park, Jinbong
    Um, Jae-Young
    Lee, Sang-Seob
    Kwak, Hyun-Jeong
    CELLS, 2019, 8 (10)
  • [28] EFFECT OF A 5-LIPOXYGENASE INHIBITOR (U-60,257B) ON ACUTE HYPOXIC PULMONARY VASOCONSTRICTION (HPV) IN ANESTHETIZED PIGS
    MCCORMACK, D
    PATERSON, N
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A151 - A151
  • [29] RELATIONSHIP BETWEEN 5-LIPOXYGENASE ACTIVATING PROTEIN GENE SG13S89G/A POLYMORPHISM AND ACUTE CORONARY SYNDROME
    He, Guoping
    Hui, Jingjiao
    Shen, Dandan
    HEART, 2011, 97
  • [30] Effects of the Cholesteryl Ester Transfer Protein Inhibitor Dalcetrapib in Patients With Recent Acute Coronary Syndrome
    Schwartz, Gregory G.
    Olsson, Anders G.
    Abt, Markus
    Ballantyne, Christie M.
    Barter, Philip
    Chaitman, Bernard R.
    Holme, Ingar M.
    Kallend, David
    Leiter, Lawrence A.
    Leitersdorf, Eran
    McMurray, John J.
    Mundl, Hardi
    Nicholls, Stephen
    Shah, Prediman K.
    Tardif, Jean-Claude
    Wright, R. S.
    CIRCULATION, 2012, 126 (23) : 2782 - 2783
12345